Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cobra Biologics Expands CMO Business | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Cobra Biologics Expands CMO Business

Birch appointed non-executive director

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

John Birch has been appointed as a non-executive director to Cobra Biologics’ board to support expansion plans. Cobra has increased capacity in the past year, along with a 40% increase in headcount.

Mr. Birch previously served as chief scientific officer for Lonza Biopharmaceuticals. In his new role, he will provide his experience and expertise in the CMO sector and will focus Cobra’s efforts to expand its service offering and capabilities.

Peter Coleman, chief executive officer of Cobra Biologics, said, “I am extremely pleased that John has decided to join Cobra’s board at a very exciting time for the company and our customers. We have set ourselves ambitious expansion targets for the year and our success has meant rapid recruitment to sustain the increased number of customer projects coming through.  The board and I look forward to working with John and our new employees to achieve our ambitious goals.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters